The death count climbed to 3,95,751 with 1,258 more fatalities due to the viral disease in a day.
A single-day rise of 50,040 fresh COVID-19 infections took India's tally to 3,02,33,183 while the number of active cases reduced to 5,86,403, according to Union Health Ministry data on Sunday.
The death count climbed to 3,95,751 with 1,258 more fatalities due to the viral disease in a day.
The number of active cases has further declined to 5,86,403 and now comprises 1.94 per cent of the total infections.
Recoveries outnumbered daily new cases of COVID-19 for the 45th consecutive day with the number of people who have recuperated from the disease surging to 2,92,51,029. The case fatality rate stood at 1.31 per cent.
While the national COVID-19 recovery rate has improved to 96.75 per cent, the weekly case positivity rate has come down to 2.91 per cent.
Here are the updates on coronavirus (COVID-19) cases:
COVID-19: More Men Got Vaccines Than Women. Centre Says Correction Needed
The pace of vaccination in the country is increasing with an average of over 60 lakh vaccinations taking place on a daily basis. But it faces the challenge of a gender gap: 54 per cent men have received the vaccine compared to 46 per cent women -- a gap of 8 per cent. In terms of population, India has only 5 per cent more men than women.
Read Here India Capable To Store Vaccines Requiring Low Temperatures: Centre Tells Supreme Court
India has the capacity to store vaccines that may require a lower temperature in the range of minus 15 to minus 20 degrees Celsius and there are over 29,000 cold chain points (CCPs) across the country where vaccines are stored at the recommended temperatures, the centre has told the Supreme Court.
Availability Of Covid Vaccine For Children Will Pave Way For Reopening Of Schools: AIIMS Chief
Making COVID-19 vaccine available for children will be a milestone achievement and pave the way for reopening of schools and resumption of outdoor activities for them, AIIMS Chief Dr Randeep Guleria has said. He said the data of phase two and three trial of Bharat Biotech's Covaxin on two to 18 years age group is expected by September. The vaccine can be available for children in India around that time following approval from the drug regulator, he said.
COVID-19: Does Delta Plus Variant Harm Lungs More? What Central Panel Chief Said
The Delta plus variant of COVID-19 has greater affinity to lung tissues as compared to other strains but it does not mean that it will cause severe disease or is more transmissible, head of coronavirus working group NTAGI Dr N K Arora said. A new viral variant of the coronavirus, Delta Plus, was identified on June 11. It was recently classified as a variant of concern.
Coronavirus News: AstraZeneca Tests Booster Vaccine Against Beta Variant Of Covid
AstraZeneca and the University of Oxford on Sunday began new trials to test a modified vaccine against the Beta variant, which first emerged in South Africa. The 'booster' vaccine's trial will involve around 2,250 participants from Britain, South Africa, Brazil and Poland.
COVID-19: Gurugram's Fortis hospital begins Sputnik V trial run for public
The Fortis Memorial Research Institute in Gurugram has started its pilot soft launch of the Russian COVID-19 vaccine ''Sputnik V'' and the hospital has procured the vaccine stock directly from Dr Reddy's Laboratories.
"The response to the pilot soft launch of the Sputnik V has been overwhelming at Fortis Memorial Research Institute, Gurugram. The vaccination launch was successfully driven in collaboration with Dr Reddy's Laboratories," said a statement issued by the Fortis Memorial Research Institute.
COVID-19: Does Delta Plus Variant Harm Lungs More? What Central Panel Chief Said
The Delta plus variant of COVID-19 has greater affinity to lung tissues as compared to other strains but it does not mean that it will cause severe disease or is more transmissible, head of coronavirus working group NTAGI Dr N K Arora said.
A new viral variant of the coronavirus, Delta Plus, was identified on June 11. It was recently classified as a variant of concern.
Till now, 51 cases of Delta Plus have been detected across 12 states, with Maharashtra reporting the maximum cases of this variant.
